Anders Mellemgaard
Nizam's Institute of Medical Sciences(IN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Multiple and Secondary Primary Cancers, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer(2008)3,206 cited
- → Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial(2014)939 cited
- → Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes(2017)774 cited
- → Obesity and cancer risk: a danish record-linkage study(1994)448 cited
- → Detection and characterization of lung cancer using cell-free DNA fragmentomes(2021)441 cited
- → Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study(2020)407 cited